Gottlieb Sees Policymaking Difficulties Ahead For FDA Under Trump

AMELIA ISLAND, FL -- Former FDA Commissioner Scott Gottlieb said the agency faces several major challenges to implementing policy in the second Trump administration, including a new White House requirement to retract 10 regulations or guidance documents for every new one that he said could not only bring new rules to a halt but also stifle use of guidance for deregulatory purposes. He also pointed to potentially increased oversight of FDA from the White House, speaking at an Association for...